Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chelation of heavy metals refers to the process by which chelating agents form stable complexes with toxic metal ions, such as lead, mercury, cadmium, and arsenic. This process is central to both natural detoxification mechanisms in living organisms and medical interventions for heavy metal poisoning. The effectiveness of a chelator depends on its ability to reach sites where metals are stored, form stable complexes at physiological pH, resist biotransformation in the body, and facilitate safe excretion without increasing toxicity. Chelation therapy is medically indicated only for acute or chronic poisoning by specific heavy metals. Potential risks include mobilization of toxic metals into sensitive organs if weak chelators unbind before elimination and depletion of essential trace elements.
Formation of stable multi-dentate ligand-metal complexes
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chelation of Heavy Metals.